E.J. Brady

430 total citations
8 papers, 223 citations indexed

About

E.J. Brady is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, E.J. Brady has authored 8 papers receiving a total of 223 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Surgery and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in E.J. Brady's work include Receptor Mechanisms and Signaling (6 papers), Pancreatic function and diabetes (4 papers) and Diabetes Treatment and Management (3 papers). E.J. Brady is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Pancreatic function and diabetes (4 papers) and Diabetes Treatment and Management (3 papers). E.J. Brady collaborates with scholars based in United States. E.J. Brady's co-authors include R Saperstein, E E Slater, Sajjad A. Qureshi, Guoqiang Jiang, Pasquale P. Vicario, Mark D. Leibowitz, Catherine A. Cullinan, Richard Saperstein, Xiaodong Yang and Mari R. Candelore and has published in prestigious journals such as Diabetes, Diabetologia and Life Sciences.

In The Last Decade

E.J. Brady

8 papers receiving 219 citations

Peers

Countries citing papers authored by E.J. Brady

Since Specialization

Citations

This map shows the geographic impact of E.J. Brady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.J. Brady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.J. Brady more than expected).

Fields of papers citing papers by E.J. Brady

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.J. Brady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.J. Brady. The network helps show where E.J. Brady may publish in the future.

Co-authorship network of co-authors of E.J. Brady

This figure shows the co-authorship network connecting the top 25 collaborators of E.J. Brady. A scholar is included among the top collaborators of E.J. Brady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.J. Brady. E.J. Brady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Chronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises circulating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese mice 2011 ·Diabetologia ·James Mu, Guoqiang Jiang, E.J. Brady, Qing Dallas-Yang, Fang Liu, J H Woods, Emanuel Zycband, Michael Wright, (unknown), Kai Lü, Lan Zhu, Xun Shen, Ranabir SinhaRoy, (unknown), Sajjad A. Qureshi, (unknown), Fuquan Zhang, Emma R. Parmee, (unknown)	59
2	A Novel Glucagon Receptor Antagonist Inhibits Glucagon-Mediated Biological Effects 2004 ·Diabetes ·Sajjad A. Qureshi, Mari R. Candelore, Dan Xie, Xiaodong Yang, Laurie Tota, Victor Ding, Zhihua Li, Alka Bansal, Corin O. Miller, Sheila M. Cohen, Guoqiang Jiang, E.J. Brady, Richard Saperstein, Joseph Duffy, James R. Tata, Kevin T. Chapman, David E. Moller, Bei B. Zhang	87
3	Beta(3)-adrenoceptor agonist-induced increases in lipolysis, metabolic rate, facial flushing, and reflex tachycardia in anesthetized rhesus monkeys. 2001 ·PubMed ·Gary J. Hom, M J Forrest, (unknown), E.J. Brady, Mari R. Candelore, Margaret A. Cascieri, David Fletcher, M. H. FISHER, Susan A. Iliff, Robert J. Mathvink, Joseph M. Metzger, (unknown), R Saperstein, Thomas L. Shih, Ann E. Weber, Matthew J. Wyvratt, Peter Zafian, D. Euan MacIntyre	11
4	NPS 1506, a moderate affinity uncompetitive NMDA receptor antagonist: preclinical summary and clinical experience 2000 ·Amino Acids ·Alan L. Mueller, Linda D. Artman, Manuel F. Balandrin, E.J. Brady, (unknown), Eric G. DelMar, (unknown), Thomas B. Marriott, Scott T. Moe, J L Raszkiewicz, (unknown), David S. Wells	3
5	Glucose-dependent alterations of intracellular free calcium by glucagon-like peptide-1(7-36amide) in individual mouse β-cells 1994 ·Cell Calcium ·Catherine A. Cullinan, E.J. Brady, R Saperstein, Mark D. Leibowitz	23
6	Effects of an α2-adrenoceptor antagonist on glucose tolerance in the genetically obese mouse ( ) 1990 ·Metabolism ·R Saperstein, (unknown), E.J. Brady, E E Slater	8
7	Insulin receptor tyrosine kinase activity is unaltered in ob/ob and db/db mouse skeletal muscle membranes 1987 ·Life Sciences ·Pasquale P. Vicario, E.J. Brady, E E Slater, R Saperstein	26
8	Synthesis of New Peptides Based on Models of Receptor-Bound Conformation 1987 ·PubMed ·Roger Freidinger, S.F. Brady, William J. Paleveda, Debra S. Perlow, C. D. COLTON, Willie L. Whitter, R Saperstein, E.J. Brady, Margaret A. Cascieri, Daniel F. Veber	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact